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Abstract
Objective
Despite rapid declines over the last two decades, coronary heart disease (CHD) mortality
rates in the British Isles are still amongst the highest in Europe. This study uses a modelling
approach to compare the potential impact of future risk factor scenarios relating to smoking
and physical activity levels, dietary salt and saturated fat intakes on future CHD mortality in
three countries: Northern Ireland (NI), Republic of Ireland (RoI) and Scotland.
Methods
CHDmortality models previously developed and validated in each country were extended
to predict potential reductions in CHD mortality from 2010 (baseline year) to 2030. Risk fac-
tor trends data from recent surveys at baseline were used to model alternative future risk
factor scenarios: Absolute decreases in (i) smoking prevalence and (ii) physical inactivity
rates of up to 15% by 2030; relative decreases in (iii) dietary salt intake of up to 30% by
2030 and (iv) dietary saturated fat of up to 6% by 2030. Probabilistic sensitivity analyses
were then conducted.
Results
Projected populations in 2030 were 1.3, 3.4 and 3.9 million in NI, RoI and Scotland respec-
tively (adults aged 25–84). In 2030: assuming recent declining mortality trends continue:
15% absolute reductions in smoking could decrease CHD deaths by 5.8–7.2%. 15% abso-
lute reductions in physical inactivity levels could decrease CHD deaths by 3.1–3.6%. Rela-
tive reductions in salt intake of 30% could decrease CHD deaths by 5.2–5.6% and a 6%
reduction in saturated fat intake might decrease CHD deaths by some 7.8–9.0%. These pro-
jections remained stable under a wide range of sensitivity analyses.
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Data Availability Statement: The IMPACT model is
an aggregate model which integrates data from a
variety of sources including publications and routine
data sources. Table S3 in the Supporting Information
details risk factor, population and mortality data
incorporated in each of the models. Additional detail
has now been included after Table S3 which outlines
the specific data archive or website where the data
used in the modelling can be accessed. Tables S5-S8
detail the: (i) age and gender stratified relative risks/
beta coefficients used in the modelling and (ii)
associated references for the publications used to
obtain the relative risks/beta coefficients.
Conclusions
Feasible reductions in four cardiovascular risk factors (already achieved elsewhere) could
substantially reduce future coronary deaths. More aggressive polices are therefore needed
in the British Isles to control tobacco, promote healthy food and increase physical activity.
Introduction
Coronary Heart Disease (CHD) mortality rates have more than halved in Northern Ireland, [1]
Republic of Ireland [2] and Scotland [3] as in other European countries over the last four
decades. However, CHD remains a leading cause of death and disability and countries in the
British Isles report unacceptable levels of premature CHDmortality compared to other North-
ern and Western European countries. [4]
However, other countries have been more successful at reducing smoking prevalence to less
than 15%, (Australia) [5] decreasing dietary salt intake (by 3g-5g) (Japan) [6] and saturated
fats (Finland), [7] and increasing physical activity (Poland). [8]
The objective of this study was therefore to evaluate the impact of a number of cardiovascu-
lar risk factor changes on future levels of CHDmortality to 2030 in three countries in the Brit-
ish Isles which have separate policy making frameworks.
The IMPACT model quantifies observed decreases in CHDmortality which can be attrib-
uted to (i) risk factor changes in the population and (ii) advances in evidence based medical
and surgical treatments. IMPACT models for Northern Ireland (1987–2007) and the Republic
of Ireland (1985–2006) were validated to assess their performance in predicting observed mor-
tality in 2010.
In this paper we extended established IMPACT models developed in Northern Ireland,
Republic of Ireland and Scotland to examine the effect of a number of improved population
level risk factor scenarios on projected CHDMortality in 2030.
Methods
The IMPACTmodel
Original IMPACT models for Northern Ireland (NI) (1987–2007) and the Republic of Ireland
(RoI) (1985–2006) were validated using the most recent year of the original model analysis, as
a base year (i.e. 2006 or 2007), to predict age and gender stratified CHD deaths in 2010. The
projected number of deaths was compared to the observed or actual number of CHD deaths in
2010 (ICD-10 codes I20-I25). “Table A in S1 Appendix”. Updated IMPACT models for each
country were extended from a baseline year of 2010 to predict the number of deaths in the year
2030. We then estimated the impact on future CHDmortality of reductions in smoking preva-
lence, reductions in prevalence of physical inactivity, reductions in systolic blood pressure due
to a fall in salt intake in the population and reduction in total cholesterol level due to replacing
diet energy from saturated fats by polyunsaturated fats or mono unsaturated fats.
Data sources
Data were sourced for each country stratified by gender and by 10-year age group for persons
aged 25–84 years “Tables B and C in S1 Appendix”). For the baseline year of the prediction
model (2010) representative national surveys were used to source risk factor data for each
country. Mortality data for 2010, population estimates for 2010 and population projections for
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2030 were obtained from official statistics agencies, the Northern Ireland Statistics & Research
Agency, Central Statistics Office and National Records of Scotland, Scottish Government for
NI, ROI and Scotland respectively. To estimate population change in CHDmortality, regres-
sion beta coefficients to quantify the impact of smoking and physical inactivity were sourced
from larger cohort studies. [9,10] Regression coefficients from meta-analyses of cohort studies
were used to quantify the mortality effects of population reductions in salt intake [11] and on
the effect of replacing dietary saturated fat intake by either polyunsaturated fats or monounsat-
urated fats. [12]
Estimating future CHDmortality to 2030
Future CHDmortality in 2030 was estimated using two approaches. Firstly, ‘lower mortality’
values for 2030 were determined by fitting age and gender specific negative exponential decay
models where future mortality decays at a rate directly proportional to historical CHD mortal-
ity. Our models used observed CHDmortality rates from 1995–2010 to determine the rate of
decay. An iterative nonlinear least squares model: y = aexp (-byear) was fitted to predict
future CHDmortality from 2010 through 2030 where a is the CHDmortality rate and b is the
constant decay rate “Figure A in S1 Appendix”. Secondly, ‘no mortality change’ 2030 CHD
mortality values were estimated using an indirect standardisation approach by multiplying
individual country age and gender specific mortality rates for 2010 by the projected population
for each 10-year age group in the year 2030.
Estimating future CHDmortality with enhanced risk factor reductions
(a) Reductions in smoking and physical inactivity. Using regression coefficients from
the literature a population attributable risk fraction (PARF) approach was used to determine
the number of deaths prevented or postponed (DPPs) in 2030 resulting from alternative
improved future smoking and physical activity levels. [13,14] The PARF was calculated con-
ventionally for 2010 and 2030 as (P x (RR-1)) / (1+P x (RR-1)) where P is the prevalence of the
risk factor and RR is the relative risk for CHDmortality associated with the individual risk fac-
tor “Example A in S1 Appendix” The number of deaths prevented was calculated as the num-
ber of deaths in 2030 multiplied by the decrease in PARF between 2010 and 2030.
(b) Reductions in cholesterol and systolic blood pressure. The effect of saturated fat
intake on serum cholesterol levels were estimated using the Clarke equations [12] to translate a
change in saturated fat intake into a change in total cholesterol levels, assuming iso-caloric
replacement with polyunsaturated and mono-saturated fats (assuming that each 1% absolute
reduction in energy from saturated fat was replaced by 0.1% energy from mono- and 0.9 energy
from poly-unsaturated fats). The differential effect of salt reduction in the diet to 2030 on sys-
tolic blood pressure in hypertensive and normotensive persons was taken from a large meta-
analysis. [11] Conventional IMPACT methodology was then used to translate the change in
systolic blood pressure levels into mortality reductions “Table D in S1 Appendix”. The updated
IMPACT model is shown in Fig 1.
For all risk factor scenarios under consideration, separate calculations for projected CHD
deaths in 2030 were undertaken based on two contrasting mortality scenarios, a) a lower mor-
tality assumption and b) conservatively assuming ‘no mortality change’ (not shown).
Cumulative benefit of multiple risk factor changes
As CHD deaths are usually caused by multiple risk factors acting together, mortality benefits
from risk factor reductions occurring simultaneously were estimated using the cumulative
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risk-reduction approach. [13] This assumes a less than additive effect of multiple risk factor
changes occurring simultaneously.
Estimating reductions in CHD deaths in 2030
Both ideal (scenario 1) and modest (scenario 2) risk factor improvements were modelled. The
ideal scenarios, although more challenging, are feasible as they have been achieved in other
countries. [7–10]
Scenario 1 –‘Ideal’ improvements in risk factors by 2030
i. absolute smoking prevalence to reduce by 15%,
ii. absolute physical inactivity rates to reduce by 15%,
iii. relative decreases in dietary salt intake of up to 30% and
iv. decreases in dietary saturated fat intake of up to 6% (absolute decreases in percentage
energy intake from saturated fats, replaced by unsaturated fats).
Scenario 2- ‘Modest’ improvements in risk factors by 2030
i. absolute smoking prevalence to reduce by 5%
ii. absolute physical inactivity rates to reduce by 5%
iii. relative decreases in dietary salt intake of up to 10% and
Fig 1. Updated IMPACT CHDModel.
doi:10.1371/journal.pone.0138044.g001
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iv. decreases in dietary saturated fat of up to 2% (absolute decreases in percentage energy
intake from saturated fats, replaced by unsaturated fats).
Extrapolation of estimates to British Isles Population
Estimated reductions in future CHD deaths for all countries in the British Isles to 2030 were
simply calculated for the combined reduction of the four risk factors under consideration. Scot-
tish projections were extrapolated to estimate deaths prevented for the populations of England
andWales.
Sensitivity analyses
Uncertainty in modelling estimates was quantified by running an iterative Monte Carlo simula-
tion using R software (R Core Team (2014). R: A language and environment for statistical com-
puting. R Foundation for Statistical Computing, Vienna, Austria. URL http://www.R-project.
org/). The model was repeated 10,000 times, using random numbers drawn from specific dis-
tributions as model input values. We calculated the uncertainty intervals based on 10,000
draws taking the 95% uncertainty intervals as the 2.5th and 97.5th percentiles. Input variables
taken from external sources (e.g. beta coefficients and relative risk reductions) were randomly
drawn from specified distributions. The distributions used for the main input parameters are
detailed in “Table L in S1 Appendix”.
Ethics Statement
Our study is a secondary data analyses of routinely available mortality, population and Health
Survey data. It thus only uses anonymised data, and additional ethical approval was therefore
not required.
Results
A validation exercise using risk factor and treatment values for the final year of original
IMPACT models for NI & RoI to predict CHD deaths in 2010 showed high levels of agreement
for NI (91%) & RoI (106%) between the predicted and actual number of CHD deaths “Table B
in S1 Appendix”.
Table 1 details baseline (2010) and future (2030) risk factor weighted average values (25–84
years) used in the models for each country. Table 2 reports modelled estimates of potentially
preventable CHD deaths (expressed as a percentage of total expected deaths in 2030) pertain-
ing to each future risk factor scenario. For a ‘lower CHDmortality in 2030’ assumption, esti-
mates of the number of CHD deaths that could potentially result from achievable ‘modest’
(scenario 1) and more optimistic ‘ideal’ (scenario 2) future risk factor scenarios are shown in
Fig 2. Separate modelling estimates based on assuming a no CHDmortality change to 2030
were also quantified “in Table J and Figure B in S1 Appendix”.
Scenario 1 –Ideal improvements in risk factors by 2030.
Based on the lower mortality assumption, a total of 150 (23.3%), 410 (23.2%) & 625(24.4%)
deaths could potentially be avoided in NI, RoI and Scotland respectively if ambitious risk factor
improvements across the four risk factor scenarios were achieved (See Fig 1). In relative terms,
there was greater potential of risk factor improvements to reduce deaths in women (between
25.1% and 25.7%) compared to men (between 22.3% and 23.8%) “Table J in S1 Appendix”.
Lowering saturated fat level intake by 6% in absolute terms would result in 55 (8.6%), 140
(7.8%) & 230 (9.0%) fewer CHD deaths in NI, RoI and Scotland respectively (the percentages
Modelling Future Coronary Heart Disease Mortality to 2030
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here are based on overall deaths potentially avoided in each country, Table 2). A substantial
but feasible reduction in smoking prevalence of 15% would result in 40 (5.8%) 110 (6.2%) &
185 (7.2%) fewer deaths in NI, RoI & Scotland. There were marked gender differences regard-
ing reduction in deaths due to smoking with greater potential relative reductions in women
(6.9%-8%) compared to men (5.4%-6.7%). Reducing salt levels in relative terms by 30% would
reduce CHD deaths by 5.2–5.6% (35, 100 & 135 fewer deaths in NI, RoI & Scotland). A slightly
higher proportion of deaths could be prevented from reduced salt intake in women (5.7%-
5.9%) compared to men (4.9%-5.4%). An absolute improvement in physical activity levels in
each country of 15% could potentially prevent 3.1–3.6% of CHD deaths in 2030 (25, 65 & 80
fewer deaths in NI, RoI & Scotland), with no gender differences.
Scenario 2—Modest improvements in risk factors by 2030.
Based on a lower mortality assumption, modest changes across the four risk factor scenarios
could result in a total of 60, 150 and 230 fewer deaths in 2030 in NI, RoI and Scotland respec-
tively. The biggest gains would come from a 2% absolute reduction in saturated fat intake levels
in decreases in deaths of 3.0–3.5% (approximately 20, 55 & 90 fewer deaths in NI, RoI and
Scotland respectively). A 5% absolute decline in smoking by 2030 would translate into 15,
Table 1. Weighted average of risk factor levels used for 2010 baseline and for 2030 projections for adults aged 25–84 years.
NI ROI Scotland
2010 2030* 2030** 2010 2030* 2030** 2010 2030* 2030**
Smoking (%) 24.1 17.7 8.7 28.0 20.4 10.7 25.4 19.5 9.8
Physical Inactivity(%)*** 42.3 39.4 29.4 41.2 37.8 27.8 62.9 59.7 49.7
Total Cholesterol (mmol/l) 5.2 5.0 4.7 5.2 5.0 4.7 5.3 5.2 4.9
SBP (mmHG) 127.8 129.0 127.7 127.0 129.0 127.7 129.1 129.3 128.0
*Scenario 1 modest scenarios
** Scenario 2 Ideal Scenarios
*** At least 150 minutes moderate activity per week or 60 minutes vigorous activity per week (or a combination of the two)
doi:10.1371/journal.pone.0138044.t001
Table 2. Predicted decreases in deaths expressed as a percentage of total expected CHD deaths in
2030 –Ideal & Modest Future Risk Factor Scenarios.
Predicted percentage* DPPAssumed lower mortality in 2030
NI RoI Sco
Ideal Scenarios
Smoking -15% 5.8 (1.5–11.0) 6.2 (-1.0–15.2) 7.2 (1.6–14.2)
Salt -30% 5.3 (3.1–8.1) 5.6 (1.6–10.3) 5.2 (2.4–8.8)
Sat/ Unsat fats -6% 8.6 (5.2–12.6) 7.8 (1.4–15.0) 9 (4.4–15.5)
Phy Inactivity -15% 3.6 (0.3–6.7) 3.6 (-0.5–8.0) 3.1 (0.3–5.5)
Modest Scenarios
Smoking -5% 2.5 (0.6–4.7) 2.3 (-0.3–5.5) 2.6 (0.6–5.0)
Salt -10% 1.9 (1.1–3.0) 2.0 (0.5–3.8) 1.9 (0.9–3.3)
Sat/ Unsat fats -2% 3.3 (2.0–4.9) 3.0 (0.5–5.7) 3.5 (1.7–5.6)
Phy Inactivity -5% 1.2 (-0.5–3.3) 1.3 (-0.5–3.3) 1.1 (0.1–2.1)
Expected Deaths 646 (439–860) 1773 (682–2936) 2562 (1324–3916)
*Expressed as a percentage of expected deaths in 2030
doi:10.1371/journal.pone.0138044.t002
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40 and 65 fewer CHD deaths (in percentage terms 2.3–2.6%). As regards salt intake, relative
decreases of 10% might decrease CHD deaths by 1.9–2.0% (approximately 10, 35 and 50 deaths
in NI, RoI and Scotland respectively). Approximately 10, 20 and 30 fewer deaths in NI, ROI
and Scotland respectively (approximate decrease of 1.1–1.3%) could be attributed to a 5% abso-
lute decrease in physical inactivity levels. For all countries, there were more marked relative
decreases in deaths in women overall and in particular declines in mortality attributed to
reductions in smoking levels and salt intake (Table I in S1 Appendix).
Fig 2. Predicted Decreases in Deaths in 2030 based on ‘Lower CHDmortality in 2030’–IDEAL Scenarios (the error bars show the extrememinimum
andmaximum values in the sensitivity analysis.
doi:10.1371/journal.pone.0138044.g002
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Modelling results based on ‘no mortality change’ scenarios resulted in marginally higher
estimates of DPPs when expressed as a percentage of total expected deaths (Table J in S1
Appendix.
Extrapolation of models estimates to British Isles population projections
for 2030
Based on the lower mortality assumption, the Scottish population of 3.9 million (25–84 years)
translated into 230 or 625 total CHD deaths prevented resulting from the ‘Modest’ and ‘Ideal’
future risk factor scenarios respectively. Simple extrapolation of deaths potentially prevented
from these Scottish estimates to the populations of England and Wales (25–84 years) of 42.4
million suggests that 2480 & 6745 fewer CHD deaths could be expected in the British Isles in
2030 (Table K in S1 Appendix).
Discussion
Our modelling estimates using data from NI, RoI and Scotland suggest that reducing four
selected risk factors could substantially decrease CHDmortality by 2030, by somewhere
between 9% (‘modest’ scenarios) and 24% (‘ideal’ scenarios).
In the year 2030 over 6,800 CHD deaths could be avoided in the British Isles by optimal
improvements in average population dietary salt and saturated fat intake, reductions in unac-
ceptable high levels of smoking prevalence and increases in physical activity levels. Alterna-
tively, if modest and very feasible improvements in the same risk factors were achieved as in
other countries, approximately 2500 CHD deaths could be avoided in the British Isles. There is
greater potential to reduce blood pressure levels in older women. Our results also reflect the
vast potential to reduce heart disease deaths in both men and in particular women. (aged over
65) resulting from increased post-menopausal risks of CHD.
Previous studies using IMPACT methodology have consistently shown a similar contribu-
tion to decreasing CHDmortality trends attributed to reduction in population risk factor levels
compared to treatments. [1,2,14] Decreases in blood pressure, total cholesterol and smoking
explained more than 60% of the decrease in CHDmortality in NI (1987–2007) [1] in ROI
(1985–2006) [2] and contributed to 50% of the CHDmortality decline in an earlier study car-
ried out in Scotland (1975–1984). [3]
Despite marked smoking declines in NI, ROI & Scotland over the last number of decades
and repeated evidence of reductions in CHDmortality due to declines in smoking prevalence,
current smoking levels in the ‘celtic fringe’ countries remain unacceptably high at approxi-
mately 25%. [15]
A large proportion of the blood pressure and cholesterol improvements in the UK over the
last 20–30 years can be attributed to changes in diet. [16,17] A recent UK wide ‘family food sur-
vey’ (2007–2009) found higher levels of saturated fat & salt intake and lower fruit and vegetable
consumption in both NI and Scotland compared to England &Wales. [18] ROI has previously
reported better uptake of at least one daily portion of fruit and vegetable intake per day com-
pared to NI. [15]
Although physical inactivity data from NI, RoI and Scotland were derived from the Interna-
tional Physical Activity (IPAQ) questionnaire, [19] markedly higher levels of physical inactivity
were reported in Scotland compared to NI & RoI. Higher inactivity in Scotland can be
explained by differing interpretations of the IPAQ questionnaire being employed as the Scot-
tish activity figures used are based on previous UK recommendations of performing at least
moderate activity lasting 30 minutes per day 5 days per week whereas NI & RoI data are
aligned with current UK recommendations of meeting at least 150 minutes of moderate
Modelling Future Coronary Heart Disease Mortality to 2030
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intensity activities per week. A recent study from the Republic of Ireland reported improving
physical activity levels in the Republic of Ireland between 1985 and 2006. [2] As devolved
administrations of the United Kingdom (UK), NI and Scotland have responsibility for much of
public health policy, although UK wide policy and law still dictate taxation, advertising and
consumer protection issues such as health warnings on tobacco products. A renewed commit-
ment to primary prevention and risk factor reduction is central to overarching public health
policies and CHD focused strategies in each country. [20–22] Similar population based preven-
tion approaches for smoking have been adopted in all three countries with continued taxation
on tobacco products and implementation of smoking bans in enclosed public places (March
2004 in RoI, March 2006 in Scotland and April 2007 in NI). However, there is substantial room
for improvement as recent survey data suggest that smoking rates are still much higher in Brit-
ish Isles countries compared to other Northern European countries. It is anticipated that NI &
Scotland will eventually follow proposals in ROI to introduce standardised plain packaging of
cigarettes. This ground breaking initiative had an immediate positive impact in Australia. [23]
Over the last few decades the UK has had some success in reducing average salt and satu-
rated levels by setting voluntary targets and by improving nutritional labelling indicating the
level of saturated fats, salt and sugars on pre-packaged foods. However, average salt intakes in
the UK and Ireland are substantially higher than the recommended intake of 6 grams per day.
[24] Bigger decreases in CHDmortality would be achieved by mandatory reformulation of pro-
cessed foods and by introducing subsidies for growing healthier foods. [25] As well as making a
huge difference to population health, the implementation of population based mandatory stan-
dards for lower levels of salt and saturated fats in processed foods is cost effective. [26] The
potential of introducing effective food policies is highlighted by recent studies which quantified
the number of CVD deaths that could be avoided in NI and Scotland and in ROI by population
level changes in diet. [27]
The overriding goal of current physical activity strategies in NI, RoI and in Scotland remains
to increase active travel. Recent UK wide co-operation to set targets of further incorporating
physical activity into daily life and to standardize physical activity definitions is encouraging.
However, more radical approaches to promote active travel such as financial incentives (selec-
tive taxes or subsidies) need to be explored for a sustained population shift from sedentary liv-
ing to more cycling and walking to be realized. [28]
Strengths and Limitations
Our study has several strengths including incorporating high quality recent risk factor trend
data from high quality national surveys and we cumulative adjusted for multiple risk factor
changing simultaneously. As ever with modelling studies there are some limitations. Projec-
tions of mortality to 2030 are likely to be speculative and uncertain. However, different
approaches to projecting mortality was considered and probabilistic sensitivity analysis per-
formed to ensure robustness of findings. Direct physical activity comparisons between coun-
tries are difficult due to self reported physical activity data being prone to bias. [29] However,
improved UK-wide physical activity guidelines were published in 2011. Our projections model
only estimate future CHD deaths although concurrent reductions in future non fatal CHD
events would also be achieved based on the future risk factors scenarios modelled.
As part of our ongoing work we will specifically model potential reductions in CHDmortal-
ity resulting from reductions in obesity, or diabetes when there is sufficient evidence of effective
population level interventions to reverse recent substantial increases in these important risk
factors. Although, population level interventions to reduce obesity and diabetes by 2030 were
not included in the current study, the rising levels of these risk factors in our population were
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taken into account as part of the baseline risk, which was used to project future absolute levels
of CHD mortality.
We did not model the effect of improvements in therapies which could also occur and
might reduce mortality further. Therefore, the model assumes no change in therapies uptake or
effectiveness over time. We did not distinguish between risk factor reduction in ‘healthy sub-
jects’ and persons with recognised heart disease, but at a population level this will have little
impact on our estimates.
The current mortality projection method did not take into account competing risks for mor-
tality. However, the model probably underestimates potential gains, as risk factors changes
such as smoking would reduce the incidence of related cancers and stroke.
It was assumed that modelled estimates of one individual country in the UK could be
extrapolated to the overall UK population and this poses the risk of accentuating any bias in
modelling estimates. However, all countries in the British Isles have similar age profiles and
cardiovascular risk factors are comparable in all countries. Validation and sensitivity analyses
carried out mitigate concerns with comparability with data across all British Isles countries.
A notable strength is the model validation highlighting the high predictive ability of original
models (>90%) in projecting mortality to 2010. As CHDmortality rates can change abruptly
over a short period of time, two contrasting future mortality scenarios were modelled. How-
ever, marked cardiovascular mortality decreases can occur rapidly following risk factor changes
in the population and our modelled estimates should not be taken as precise projections but as
useful indicators of future CHDmortality which might be expected based on different future
risk factor scenarios. [30]
Conclusions
CHDmortality improvements have been a major success story over recent decades. Yet with-
out further policy action, the future burden and cost of treating CHD could increase exponen-
tially. And CHD is largely preventable. However, radical policies will be needed to further
improve diet and reduce smoking in order to minimise the future burden of CHD.
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